| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0012700 | Exon-Exon | chr7:122130135-122153369 | chr7:122490081-122513315 | 377 nt | 0.4085 |
| hsa_CADPS2_0012900 | Intron-Exon-Intron | chr7:122130135-122170252 | chr7:122490081-122530198 | 201 nt | 0.4179 |
| hsa_CADPS2_0013000 | Exon-Exon | chr7:122130135-122194743 | chr7:122490081-122554689 | 213 nt | 0.3803 |
| hsa_CADPS2_0013100 | Intron-Exon-Intron | chr7:122130135-122221852 | chr7:122490081-122581798 | 197 nt | 0.4112 |
| hsa_CADPS2_0013200 | Exon-Exon | chr7:122130135-122261771 | chr7:122490081-122621717 | 438 nt | 0.3927 |
| hsa_CADPS2_0013300 | Exon-Exon | chr7:122130135-122269382 | chr7:122490081-122629328 | 81 nt | 0.4938 |
| hsa_CADPS2_0012800 | Exon-Exon | chr7:122130135-122303623 | chr7:122490081-122663569 | 1399 nt | 0.4196 |
| hsa_CADPS2_0013400 | Exon-Exon | chr7:122131366-122269382 | chr7:122491312-122629328 | 87 nt | 0.5057 |
| hsa_CADPS2_0013500 | Intron-Intron | chr7:122138251-122141089 | chr7:122498197-122501035 | 2839 nt | 0.3332 |
| hsa_chr7_0099400 | Intergenic-Intergenic | chr7:122143627-122149797 | chr7:122503573-122509743 | 250 nt | 0.2680 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].